Valproic acid causes proteasomal degradation of DICER and influences miRNA expression

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Zhang, Zhaiyi ^a   Convertini, Paolo ^a   Shen, Manli ^a   Xu, Xiu ^a   Lemoine, Frédéric ^b   De La Grange, Pierre ^b   Andres, Douglas A ^a   Stamm, Stefan ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DICER; MICRORNA; VALPROIC ACID;

ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; ENZYME DEFICIENCY; ENZYME DEGRADATION; ENZYME REGULATION; GENE CONTROL; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; PROTEIN RNA BINDING; UPREGULATION;

CELLS, CULTURED; DEAD-BOX RNA HELICASES; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HEK293 CELLS; HELA CELLS; HUMANS; MICROARRAY ANALYSIS; MICRORNAS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEOLYSIS; RIBONUCLEASE III; VALPROIC ACID;

EID: 84892906480     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0082895     Document Type: Article

References (48)

1. Stephen LJ (2003) Drug treatment of epilepsy in elderly people: focus on valproic Acid. Drugs Aging 20: 141-152. PubMed: 12534314.
2. Frazee LA, Foraker KC (2008) Use of intravenous valproic acid for acute migraine. Ann Pharmacother 42: 403-407. doi:10.1345/aph.1K531. PubMed: 18303140.
3. Rosenberg G (2007) The mechanisms of action of valproate in neuropsychiatric disorders: can we see the forest for the trees? Cell Mol Life Sci 64: 2090-2103. doi:10.1007/s00018-007-7079-x. PubMed: 17514356.
4. Kissel JT, Scott CB, Reyna SP, Crawford TO, Simard LR et al. (2011) SMA CARNIVAL TRIAL PART II: a prospective, single-armed trial of L-carnitine and valproic acid in ambulatory children with spinal muscular atrophy. PLOS ONE 6: e21296. doi:10.1371/journal.pone.0021296. PubMed: 21754985.
5. Tan J, Cang S, Ma Y, Petrillo RL, Liu D (2010) Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents. J Hematol Oncol 3: 5. PubMed: 20132536.
6. Duenas-Gonzalez A, Candelaria M, Perez-Plascencia C, Perez-Cardenas E, de la Cruz-Hernandez E et al. (2008) Valproic acid as epigenetic cancer drug: preclinical, clinical and transcriptional effects on solid tumors. Cancer Treat Rev 34: 206-222. doi:10.1016/j.ctrv.2007.11.003. PubMed: 18226465.
7. Michaelis M, Doerr HW, Cinatl J Jr. (2007) Valproic acid as anti-cancer drug. Curr Pharm Des 13: 3378-3393. doi:10.2174/138161207782360528. PubMed: 18045192.
8. Phiel CJ, Zhang F, Huang EY, Guenther MG, Lazar MA et al. (2001) Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J Biol Chem 276: 36734-36741. doi:10.1074/jbc. M101287200. PubMed: 11473107.
9. Yuan PX, Huang LD, Jiang YM, Gutkind JS, Manji HK et al. (2001) The mood stabilizer valproic acid activates mitogen-activated protein kinases and promotes neurite growth. J Biol Chem 276: 31674-31683. doi:10.1074/jbc. M104309200. PubMed: 11418608.
10. Krämer OH, Zhu P, Ostendorff HP, Golebiewski M, Tiefenbach J et al. (2003) The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2. EMBO J 22: 3411-3420. doi:10.1093/emboj/ cdg315. PubMed: 12840003.
11. St-Germain JR, Chen J, Li Q (2008) Involvement of PML nuclear bodies in CBP degradation through the ubiquitin-proteasome pathway. Epigenetics : Official Journal of the DNA Methylation Society 3: 342-349. doi:10.4161/epi.3.6.7203. PubMed: 19011377.
12. Fukuchi M, Nii T, Ishimaru N, Minamino A, Hara D et al. (2009) Valproic acid induces up- or down-regulation of gene expression responsible for the neuronal excitation and inhibition in rat cortical neurons through its epigenetic actions. Neurosci Res 65: 35-43. doi:10.1016/j.neures.2009.09.1698. PubMed: 19463867.
13. Bosetti F, Bell JM, Manickam P (2005) Microarray analysis of rat brain gene expression after chronic administration of sodium valproate. Brain research bulletin 65: 331-338.
14. Chetcuti A, Adams LJ, Mitchell PB, Schofield PR (2006) Altered gene expression in mice treated with the mood stabilizer sodium valproate. The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum 9: 267-276
15. Kim VN, Han J, Siomi MC (2009) Biogenesis of small RNAs in animals. Nat Rev Mol Cell Biol 10: 126-139. doi:10.1038/nrm2632. PubMed: 19165215.
16. Krol J, Busskamp V, Markiewicz I, Stadler MB, Ribi S et al. (2010) Characterizing light-regulated retinal microRNAs reveals rapid turnover as a common property of neuronal microRNAs. Cell 141: 618-631. doi:10.1016/j.cell. 2010.03.039. PubMed: 20478254.
17. Gibbings D, Mostowy S, Jay F, Schwab Y, Cossart P et al. (2012) Selective autophagy degrades DICER and AGO2 and regulates miRNA activity. Nat Cell Biol 14: 1314-1321. doi:10.1038/ncb2611. PubMed: 23143396.
18. Gantier MP, McCoy CE, Rusinova I, Saulep D, Wang D et al. (2011) Analysis of microRNA turnover in mammalian cells following Dicer1 ablation. Nucleic Acids Res 39: 5692-5703. doi:10.1093/nar/gkr148. PubMed: 21447562.
19. Jimenez-Mateos EM, Engel T, Merino-Serrais P, McKiernan RC, Tanaka K et al. (2012) Silencing microRNA-134 produces neuroprotective and prolonged seizure-suppressive effects. Nat Med 18: 1087-1094. doi:10.1038/nm.2834. PubMed: 22683779.
20. Swoboda KJ, Scott CB, Reyna SP, Prior TW, LaSalle B et al. (2009) Phase II open label study of valproic acid in spinal muscular atrophy. PLOS ONE 4: e5268. doi:10.1371/journal.pone.0005268. PubMed: 19440247.
21. Kanehisa M, Goto S, Sato Y, Furumichi M, Tanabe M (2012) KEGG for integration and interpretation of large-scale molecular data sets. Nucleic Acids Res 40: D109-D114. doi:10.1093/nar/gkr988. PubMed: 22080510.
22. Schmitter D, Filkowski J, Sewer A, Pillai RS, Oakeley EJ et al. (2006) Effects of Dicer and Argonaute down-regulation on mRNA levels in human HEK293 cells. Nucleic Acids Res 34: 4801-4815. doi:10.1093/nar/gkl646. PubMed: 16971455.
23. Reed RC, Dutta S, Cavanaugh JH, Locke C, Granneman GR (2006) Every-12-hour administration of extended-release divalproex in patients with epilepsy: impact on plasma valproic acid concentrations. Epilepsy & behavior. E&B 8: 391-396.
24. Meng L, Mohan R, Kwok BH, Elofsson M, Sin N et al. (1999) Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity. Proc Natl Acad Sci U S A 96: 10403-10408. doi:10.1073/pnas.96.18. 10403. PubMed: 10468620.
25. Yoshimori T, Yamamoto A, Moriyama Y, Futai M, Tashiro Y (1991) Bafilomycin A1, a specific inhibitor of vacuolar-type H(+)-ATPase, inhibits acidification and protein degradation in lysosomes of cultured cells. J Biol Chem 266: 17707-17712. PubMed: 1832676.
26. Mizushima N, Yoshimori T (2007) How to interpret LC3 immunoblotting. Autophagy 3: 542-545. PubMed: 17611390.
27. Kanellopoulou C, Muljo SA, Kung AL, Ganesan S, Drapkin R et al. (2005) Dicer-deficient mouse embryonic stem cells are defective in differentiation and centromeric silencing. Genes Dev 19: 489-501. doi:10.1101/gad.1248505. PubMed: 15713842.
28. Cifuentes D, Xue H, Taylor DW, Patnode H, Mishima Y et al. (2010) A novel miRNA processing pathway independent of Dicer requires Argonaute2 catalytic activity. Science 328: 1694-1698. doi:10.1126/science.1190809. PubMed: 20448148.
29. Wu J, Qian J, Li C, Kwok L, Cheng F et al. (2010) miR-129 regulates cell proliferation by downregulating Cdk6 expression. Cell Cycle 9: 1809-1818. doi:10.4161/cc.9.9.11535. PubMed: 20404570.
30. Sowa ME, Bennett EJ, Gygi SP, Harper JW (2009) Defining the human deubiquitinating enzyme interaction landscape. Cell 138: 389-403. doi:10.1016/j.cell.2009.04.042. PubMed: 19615732.
31. Taylor DD, Zacharias W, Gercel-Taylor C (2011) Exosome isolation for proteomic analyses and RNA profiling. Methods Mol Biol 728: 235-246. doi:10.1007/978-1-61779-068-3-15. PubMed: 21468952.
32. Nagaraja AK, Andreu-Vieyra C, Franco HL, Ma L, Chen R et al. (2008) Deletion of Dicer in somatic cells of the female reproductive tract causes sterility. Mol Endocrinol 22: 2336-2352. doi:10.1210/me.2008-0142. PubMed: 18687735.
33. Chen JF, Murchison EP, Tang R, Callis TE, Tatsuguchi M et al. (2008) Targeted deletion of Dicer in the heart leads to dilated cardiomyopathy and heart failure. Proc Natl Acad Sci U S A 105: 2111-2116. doi:10.1073/pnas. 0710228105. PubMed: 18256189.
34. Vlachos IS, Kostoulas N, Vergoulis T, Georgakilas G, Reczko M et al. (2012) DIANA miRPath v.2.0: investigating the combinatorial effect of microRNAs in pathways. Nucleic Acids Res 40: W498-W504. doi:10.1093/nar/gks494. PubMed: 22649059.
35. Chodurek E, Orchel A, Orchel J, Kurkiewicz S, Gawlik N et al. (2012) Evaluation of melanogenesis in A-375 melanoma cells treated with 5,7-dimethoxycoumarin and valproic acid. Cell Mol Biol Lett 17: 616-632. PubMed: 23001511.
36. Damiani D, Alexander JJ, O'Rourke JR, McManus M, Jadhav AP et al. (2008) Dicer inactivation leads to progressive functional and structural degeneration of the mouse retina. J Neurosci 28: 4878-4887. doi:10.1523/JNEUROSCI.0828-08. 2008. PubMed: 18463241.
37. Reed RC, Dutta S (2006) Does it really matter when a blood sample for valproic acid concentration is taken following once-daily administration of divalproex-ER? Ther Drug Monit 28: 413-418. doi:10.1097/01.ftd.0000211814.12311. 3f. PubMed: 16778728.
38. Asada S, Takahashi T, Isodono K, Adachi A, Imoto H et al. (2008) Downregulation of Dicer expression by serum withdrawal sensitizes human endothelial cells to apoptosis. Am J Physiol Heart Circ Physiol 295: H2512-H2521. doi:10.1152/ajpheart.00233.2008. PubMed: 18978195.
39. Wiesen JL, Tomasi TB (2009) Dicer is regulated by cellular stresses and interferons. Mol Immunol 46: 1222-1228. doi:10.1016/j.molimm.2008.11.012. PubMed: 19118902.
40. Kaneko H, Dridi S, Tarallo V, Gelfand BD, Fowler BJ et al. (2011) DICER1 deficit induces Alu RNA toxicity in age-related macular degeneration. Nature 471: 325-330. doi:10.1038/nature09830. PubMed: 21297615.
41. McKiernan RC, Jimenez-Mateos EM, Bray I, Engel T, Brennan GP et al. (2012) Reduced mature microRNA levels in association with dicer loss in human temporal lobe epilepsy with hippocampal sclerosis. PLOS ONE 7: e35921. doi:10.1371/journal.pone.0035921. PubMed: 22615744.
42. Kapur K, Jiang H, Xing Y, Wong WH (2008) Cross-hybridization modeling on Affymetrix exon arrays. Bioinformatics 24: 2887-2893. doi:10.1093/ bioinformatics/btn571. PubMed: 18984598.
43. Shen S, Warzecha CC, Carstens RP, Xing Y (2010) MADS+: discovery of differential splicing events from Affymetrix exon junction array data. Bioinformatics 26: 268-269. doi:10.1093/bioinformatics/btp643. PubMed: 19933160.
44. Huang da W, Sherman BT, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4: 44-57. PubMed: 19131956.
45. Petak I, Douglas L, Tillman DM, Vernes R, Houghton JA (2000) Pediatric rhabdomyosarcoma cell lines are resistant to Fas-induced apoptosis and highly sensitive to TRAIL-induced apoptosis. Clin Cancer Res 6: 4119-4127. PubMed: 11051265.
46. Novoyatleva T, Heinrich B, Tang Y, Benderska N, Butchbach ME et al. (2008) Protein phosphatase 1 binds to the RNA recognition motif of several splicing factors and regulates alternative pre-mRNA processing. Hum Mol Genet, 17: 52-70. PubMed: 17913700.
47. Kishore S, Khanna A, Zhang Z, Hui J, Balwierz PJ et al. (2010) The snoRNA MBII-52 (SNORD 115) is processed into smaller RNAs and regulates alternative splicing. Hum Mol Genet 19: 1153-1164. doi:10.1093/hmg/ddp585. PubMed: 20053671.
48. Falaleeva M, Sulsona CR, Zielke HR, Currey KM, de la Grange P et al. (2013) Molecular Characterization of a Patient presumed to have Prader-Willi Syndrome: a case report. Clinical Med In: Case reports: in press.